Search Word(s)    
Search in   
  Fuzzy Searching 
Sorted by date    Sort by relevance

INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
18666 bytes   6/2/2026 12:00:02 PM GMT
https://www.tmcnet.com/usubmit/2026/06/02/10392364.htm (10392364)
Jerry Masseur is Promoted to Chief Sales Officer at Magna5
6464 bytes   6/1/2026 12:02:24 PM GMT
https://www.tmcnet.com/usubmit/2026/06/01/10391570.htm (10391570)
Shelly Ashwill, Seasoned Technology and Operations Leader, Joins the Exceptional Women Alliance (EWA)
7092 bytes   5/28/2026 1:03:45 PM GMT
https://www.tmcnet.com/usubmit/2026/05/28/10390409.htm (10390409)
Linus Health Digital Cognitive Assessments Meet or Surpass New CEOi Benchmarks for Early Cognitive Impairment Detection
14827 bytes   5/27/2026 2:01:20 PM GMT
https://www.tmcnet.com/usubmit/2026/05/27/10389593.htm (10389593)
ki:elements Detects Alzheimer's Pathology via Automated Phone Call: Study Validates Speech Biomarker Across Five European Cohorts
6924 bytes   5/20/2026 1:06:15 PM GMT
https://www.tmcnet.com/usubmit/2026/05/20/10386485.htm (10386485)
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
26780 bytes   5/15/2026 10:30:01 AM GMT
https://www.tmcnet.com/usubmit/2026/05/15/10383766.htm (10383766)
Barings Corporate Investors Reports Preliminary First Quarter 2026 Results and Announces Quarterly Cash Dividend Of $0.40 Per Share
12229 bytes   5/14/2026 7:30:04 PM GMT
https://www.tmcnet.com/usubmit/2026/05/14/10383537.htm (10383537)
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
14384 bytes   5/14/2026 12:00:04 PM GMT
https://www.tmcnet.com/usubmit/2026/05/14/10382956.htm (10382956)
Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease
31969 bytes   5/8/2026 6:30:02 AM GMT
https://www.tmcnet.com/usubmit/2026/05/08/10379468.htm (10379468)
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease
11798 bytes   4/30/2026 11:00:03 AM GMT
https://www.tmcnet.com/usubmit/2026/04/30/10374343.htm (10374343)

1   2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  NEXT